Monitor for any follow-up filings related to the recent officer departure or the outcome of the annual meeting vote.
Price Chart
Executive Summary
Arcus Biosciences, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor appointment ratification, and executive compensation. This is a routine proxy filing, not a shareholder vote outcome. A recent officer departure filing suggests potential governance issues, but the proxy itself is standard.
Key Facts
- Filing is a DEFA14A, the definitive proxy statement for the 2026 Annual Meeting.
- Vote items include the election of four directors, ratification of Ernst & Young as auditors, and advisory approval of executive compensation.
- A recent 8-K filing (March 23, 2026) reported the departure of an officer, which may indicate internal changes.
- The filing is routine and does not contain material financial information or significant strategic announcements.
Financial Impact
No material financial impact from this filing.
Risk Factors
- The recent officer departure may indicate potential governance or strategic instability.
- The outcome of the shareholder vote, while expected to pass, could be influenced by activist sentiment if present.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001724521-26-000026 |
| Document: 0001724521-26-000026-index-headers.html | 0001724521-26-000026 |
| Document: 0001724521-26-000026-index.html | 0001724521-26-000026 |
| Document: 0001724521-26-000026.txt | 0001724521-26-000026 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 144 | $28.92 $28.62 | ▼ −1.04% | ▼ −3.46% | $24.27 (−16.08%) |
Apr 21, 2026 23w ago | DEFA14A | $26.62 $22.75 | ▼ −14.54% | ▼ −17.70% | $24.27 (−8.83%) |
Apr 20, 2026 23w ago | 8-K | $22.74 $23.40 | ▼ −2.90% | ▲ +1.30% | $24.27 (−6.73%) |
Apr 8, 2026 25w ago | 144 | $23.28 $26.00 | ▲ +11.68% | ▲ +4.12% | $24.27 (+4.25%) |
Feb 25, 2026 31w ago | 8-K | $20.27 $21.46 | ▲ +5.87% | ▲ +11.11% | $24.27 (+19.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access